GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Offer for Sale

Glenmark Pharmaceuticals Ltd.

NSE: GLENMARK | BSE: 532296 | ISIN: INE935A01035 | Industry: Pharmaceuticals
| Strong Performer, Getting Expensive

2019.6000 -43.20 (-2.09%)

NSE Aug 08, 2025 15:31 PM

58.34% Gain from 52W Low

Volume: 297.5K

Glenmark Pharmaceuticals Ltd.

10 Jul 2024

2019.60

-2.09%

Company Update

GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Offer for Sale

BSE India

Offer for sale is attached for reference and record.

More from Glenmark Pharmaceuticals Ltd.

Recommended

Five Interesting Stocks Today - August 8, 2025

The Baseline | 08 Aug 2025, 05:14PM

Market closes lower, SBI's Q1 net profit grows 12.5% YoY to Rs 19,160.4 crore

Trendlyne Marketwatch | 08 Aug 2025, 03:58PM

Earnings Call Transcript - Q4FY20 for Glenmark Pharmaceuticals